{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:00:24Z","timestamp":1793818824362,"version":"4.6.1"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>Trigeminal postherpetic neuralgia (TG-PHN) is a neuropathic pain condition complicating herpes zoster (HZ) attributed to the trigeminal nerve. It poses significant challenges due to its persistent and debilitating nature. This review explores the clinical characteristics of TG-PHN, analyzes its pathophysiological underpinnings, and addresses existent and potential therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>TG-PHN is one of the most common and complex PHN locations. It has distinguishing clinical and pathophysiological characteristics, starting with viral triggered injuries to the trigeminal ganglion (TG) and peripheral tissue and involving the ascending and descending brain modulation pathways. Current therapies include vaccines, oral and topical medications, and interventional approaches, like nerve blocks and neurostimulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>This review covers TG-PHN\u2019s clinical and physiological components, treatment options, and potential future targets for improved management. By exploring the complexities of this condition, we aim to contribute to developing more effective and targeted therapies for patients suffering from trigeminal PHN.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11916-023-01209-z","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T06:02:06Z","timestamp":1705989726000},"page":"295-306","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Trigeminal Postherpetic Neuralgia: From Pathophysiology to Treatment"],"prefix":"10.1007","volume":"28","author":[{"given":"Christy S.","family":"Niemeyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Harlander-Locke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew N.","family":"Bubak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Rzasa-Lynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Birlea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,23]]},"reference":[{"issue":"15016","key":"1209_CR1","first-page":"2015","volume":"1","author":"A Gershon","year":"2015","unstructured":"Gershon A, et al. Varicella zoster virus infection. Nat Rev Dis Primers. 2015;1(15016):2015.","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"1209_CR2","doi-asserted-by":"publisher","first-page":"e3210","DOI":"10.1093\/cid\/ciaa1185","volume":"73","author":"RR Thompson","year":"2021","unstructured":"Thompson RR, et al. Herpes zoster and postherpetic neuralgia: changing incidence rates from 1994 to 2018 in the United States. Clin Infect Dis. 2021;73(9):e3210\u20137.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1209_CR3","doi-asserted-by":"publisher","first-page":"946","DOI":"10.3390\/jcm9040946","volume":"9","author":"P-W Tsau","year":"2020","unstructured":"Tsau P-W, et al. Clinical presentations and outcome studies of cranial nerve involvement in herpes zoster infection: a retrospective single-center analysis. J Clin Med. 2020;9(4):946.","journal-title":"J Clin Med"},{"issue":"4","key":"1209_CR4","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.idc.2017.07.016","volume":"31","author":"AR John","year":"2017","unstructured":"John AR, Canaday DH. Herpes zoster in the older adult. Infect Dis Clin North Am. 2017;31(4):811\u201326.","journal-title":"Infect Dis Clin North Am"},{"issue":"3","key":"1209_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ophtha.2012.09.007","volume":"120","author":"DS Borkar","year":"2013","unstructured":"Borkar DS, et al. Incidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation Study. Ophthalmology. 2013;120(3):451\u20136.","journal-title":"Ophthalmology"},{"issue":"1","key":"1209_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1533-2500.2007.00164.x","volume":"8","author":"A Sadosky","year":"2008","unstructured":"Sadosky A, et al. A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions. Pain Pract. 2008;8(1):45\u201356.","journal-title":"Pain Pract"},{"issue":"2","key":"1209_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/0333102419893823","volume":"40","author":"T Orofacial","year":"2020","unstructured":"Orofacial T. International classification of orofacial pain, (ICOP). Cephalalgia. 2020;40(2):129\u2013221.","journal-title":"Cephalalgia"},{"issue":"1","key":"1209_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/j.pain.0000000000001365","volume":"160","author":"J Scholz","year":"2019","unstructured":"Scholz J, et al. The IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain. 2019;160(1):53\u20139.","journal-title":"Pain"},{"key":"1209_CR9","doi-asserted-by":"crossref","unstructured":"ICHD. Headache classification committee of the international headache society (IHS) the international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1\u2013211.","DOI":"10.1177\/0333102417738202"},{"key":"1209_CR10","doi-asserted-by":"crossref","unstructured":"Harbecke R, Cohen JI, Oxman MN. Herpes zoster vaccines. J Infect Dis. 2021;224(12 Suppl 2):S429\u201342.","DOI":"10.1093\/infdis\/jiab387"},{"key":"1209_CR11","doi-asserted-by":"crossref","unstructured":"Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4(6):e004833.","DOI":"10.1136\/bmjopen-2014-004833"},{"issue":"3","key":"1209_CR12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/00000542-200003000-00013","volume":"92","author":"M Pappagallo","year":"2000","unstructured":"Pappagallo M, et al. Heterogenous patterns of sensory dysfunction in postherpetic neuralgia suggest multiple pathophysiologic mechanisms. Anesthesiology. 2000;92(3):691\u20138.","journal-title":"Anesthesiology"},{"issue":"9","key":"1209_CR13","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1056\/NEJM200003023420906","volume":"342","author":"DH Gilden","year":"2000","unstructured":"Gilden DH, et al. Neurologic complications of the reactivation of varicella\u2013zoster virus. N Engl J Med. 2000;342(9):635\u201345.","journal-title":"N Engl J Med"},{"issue":"1","key":"1209_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/jnnp.15.1.45","volume":"15","author":"WF Tatlow","year":"1952","unstructured":"Tatlow WF. Herpes zoster ophthalmicus and post-herpetic neuralgia. J Neurol Neurosurg Psychiatry. 1952;15(1):45\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"1209_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/bjo.71.5.353","volume":"71","author":"S Harding","year":"1987","unstructured":"Harding S, Lipton J, Wells J. Natural history of herpes zoster ophthalmicus: predictors of postherpetic neuralgia and ocular involvement. Br J Ophthalmol. 1987;71(5):353\u20138.","journal-title":"Br J Ophthalmol"},{"key":"1209_CR16","doi-asserted-by":"crossref","unstructured":"\u2022 Park C, et al. The relative frequency of pruritus in postherpetic neuralgia patients presenting to the pain clinic and associative factors. Medicine (Baltimore). 2022;101(35):e30208. Paper investigating rarely studied but pathophysiologically relevant, postherpetic pruritus in patients with PHN.","DOI":"10.1097\/MD.0000000000030208"},{"issue":"1","key":"1209_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/j.pain.0000000000000307","volume":"157","author":"HJ Forbes","year":"2016","unstructured":"Forbes HJ, et al. A systematic review and meta-analysis of risk factors for postherpetic neuralgia. Pain. 2016;157(1):30\u201354.","journal-title":"Pain"},{"issue":"1","key":"1209_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/0022034511411300","volume":"91","author":"AF DaSilva","year":"2012","unstructured":"DaSilva AF, DosSantos MF. The role of sensory fiber demography in trigeminal and postherpetic neuralgias. J Dent Res. 2012;91(1):17\u201324.","journal-title":"J Dent Res"},{"issue":"5","key":"1209_CR19","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1365-4632.2009.03929.x","volume":"48","author":"S Nithyanandam","year":"2009","unstructured":"Nithyanandam S, et al. Eruption severity and characteristics in herpes zoster ophthalmicus: correlation with visual outcome, ocular complications, and postherpetic neuralgia. Int J Dermatol. 2009;48(5):484\u20137.","journal-title":"Int J Dermatol"},{"issue":"12","key":"1209_CR20","doi-asserted-by":"publisher","first-page":"12181","DOI":"10.21037\/apm-21-3028","volume":"10","author":"H Zhou","year":"2021","unstructured":"Zhou H, et al. A systematic review and meta-analysis of independent risk factors for postherpetic neuralgia. Ann Palliat Med. 2021;10(12):12181\u20139.","journal-title":"Ann Palliat Med"},{"key":"1209_CR21","doi-asserted-by":"crossref","unstructured":"Fujiwara A, et al. Correlation between pain catastrophizing in acute herpes zoster and postherpetic neuralgia: a retrospective analysis. J Anesth. 2023.","DOI":"10.1007\/s00540-023-03208-1"},{"issue":"2","key":"1209_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/jmv.25304","volume":"91","author":"F Drago","year":"2019","unstructured":"Drago F, et al. Acute pain and postherpetic neuralgia related to varicella zoster virus reactivation: comparison between typical herpes zoster and zoster sine herpete. J Med Virol. 2019;91(2):287\u201395.","journal-title":"J Med Virol"},{"issue":"1","key":"1209_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3109\/13550289509111018","volume":"1","author":"R Mahalingam","year":"1995","unstructured":"Mahalingam R, et al. Persistence of varicalla-zoster virus DNA in elderly patients with postherpetic neuralgia. J Neurovirol. 1995;1(1):130\u20133.","journal-title":"J Neurovirol"},{"key":"1209_CR24","doi-asserted-by":"crossref","unstructured":"Bubak AN, et al. Zoster-associated prothrombotic plasma exosomes and increased stroke risk. J Infect Dis. 2022.","DOI":"10.1093\/infdis\/jiac405"},{"issue":"11","key":"1209_CR25","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/cid\/ciu098","volume":"58","author":"SM Langan","year":"2014","unstructured":"Langan SM, et al. Risk of stroke following herpes zoster: a self-controlled case-series study. Clin Infect Dis. 2014;58(11):1497\u2013503.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1209_CR26","doi-asserted-by":"publisher","first-page":"770","DOI":"10.5858\/2001-125-0770-VZVIOT","volume":"125","author":"B Kleinschmidt-DeMasters","year":"2001","unstructured":"Kleinschmidt-DeMasters B, Gilden DH. Varicella-zoster virus infections of the nervous system: clinical and pathologic correlates. Arch Pathol Lab Med. 2001;125(6):770\u201380.","journal-title":"Arch Pathol Lab Med"},{"key":"1209_CR27","doi-asserted-by":"crossref","unstructured":"Prakash S, Dave A, Joshi H. Herpes zoster ophthalmicus evolving into headache characterised as hemicrania continua. BMJ Case Rep. 2018;2018.","DOI":"10.1136\/bcr-2018-224235"},{"issue":"2","key":"1209_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1177\/0333102416677052","volume":"38","author":"T Mathew","year":"2018","unstructured":"Mathew T, et al. Post herpes zoster SUNCT like syndrome: insights from two case reports. Cephalalgia. 2018;38(2):399\u2013401.","journal-title":"Cephalalgia"},{"key":"1209_CR29","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Rehm S, et al. Sensory symptom profiles differ between trigeminal and thoracolumbar postherpetic neuralgia. Pain Rep. 2018;3(1):e636. Paper investigating the distinct sensory symptom profiles of patients with trigeminal PHN compared to those with PHN in the thoracolumbar region.","DOI":"10.1097\/PR9.0000000000000636"},{"issue":"1\u20132","key":"1209_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0304-3959(01)00400-6","volume":"96","author":"AL Oaklander","year":"2002","unstructured":"Oaklander AL, Cohen SP, Raju SV. Intractable postherpetic itch and cutaneous deafferentation after facial shingles. Pain. 2002;96(1\u20132):9\u201312.","journal-title":"Pain"},{"issue":"15","key":"1209_CR31","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1212\/WNL.0b013e318232ac46","volume":"77","author":"MA Nagel","year":"2011","unstructured":"Nagel MA, Gilden D. The trigeminal trophic syndrome. Neurology. 2011;77(15):1499\u20131499.","journal-title":"Neurology"},{"issue":"1","key":"1209_CR32","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4103\/0019-5154.174162","volume":"61","author":"S Caccavale","year":"2016","unstructured":"Caccavale S, Caccavale T, La Montagna M. Post herpes zoster trigeminal trophic syndrome in a child: an example of immunocompromised district. Indian J Dermatol. 2016;61(1):124.","journal-title":"Indian J Dermatol"},{"key":"1209_CR33","first-page":"6815407","volume":"2018","author":"A Kodama-Takahashi","year":"2018","unstructured":"Kodama-Takahashi A, et al. Neurotrophic keratopathy after trigeminal nerve block for treatment of postherpetic neuralgia. Case Rep Ophthalmol Med. 2018;2018:6815407.","journal-title":"Case Rep Ophthalmol Med"},{"issue":"2","key":"1209_CR34","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ejp.537","volume":"19","author":"T Schlereth","year":"2015","unstructured":"Schlereth T, et al. Association between pain, central sensitization and anxiety in postherpetic neuralgia. Eur J Pain. 2015;19(2):193\u2013201.","journal-title":"Eur J Pain"},{"issue":"1","key":"1209_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40122-022-00451-4","volume":"12","author":"X Cao","year":"2023","unstructured":"Cao X, et al. A meta-analysis of randomized controlled trials comparing the efficacy and safety of pregabalin and gabapentin in the treatment of postherpetic neuralgia. Pain Ther. 2023;12(1):1\u201318.","journal-title":"Pain Ther"},{"issue":"6","key":"1209_CR36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1600-0714.2006.00489.x","volume":"36","author":"FK Alvarez","year":"2007","unstructured":"Alvarez FK, et al. Evaluation of the sensation in patients with trigeminal post-herpetic neuralgia. J Oral Pathol Med. 2007;36(6):347\u201350.","journal-title":"J Oral Pathol Med"},{"issue":"3","key":"1209_CR37","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.pain.2008.08.018","volume":"140","author":"A Truini","year":"2008","unstructured":"Truini A, et al. Pathophysiology of pain in postherpetic neuralgia: a clinical and neurophysiological study. Pain. 2008;140(3):405\u201310.","journal-title":"Pain"},{"issue":"9","key":"1209_CR38","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S1474-4422(03)00506-4","volume":"2","author":"R Hevner","year":"2003","unstructured":"Hevner R, et al. An unusual cause of trigeminal-distribution pain and tumour. Lancet Neurol. 2003;2(9):567\u201371.","journal-title":"Lancet Neurol"},{"issue":"5","key":"1209_CR39","doi-asserted-by":"publisher","first-page":"490","DOI":"10.21037\/qims.2016.01.07","volume":"6","author":"A D\u2019Amico","year":"2016","unstructured":"D\u2019Amico A, et al. Can pontine trigeminal T2-hyperintensity suggest herpetic etiology of trigeminal neuralgia? Quant Imaging Med Surg. 2016;6(5):490.","journal-title":"Quant Imaging Med Surg"},{"key":"1209_CR40","doi-asserted-by":"crossref","unstructured":"Yoshida S, et al. Involvement of the spinal trigeminal nucleus secondary to herpes zoster in a patient with hemifacial redness and swelling. J Cutan Immunol Allergy. 2022;5(6):238\u20139.","DOI":"10.1002\/cia2.12262"},{"key":"1209_CR41","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2147\/JPR.S352105","volume":"15","author":"X Liu","year":"2022","unstructured":"Liu X, et al. MRI study of cerebral cortical thickness in patients with herpes zoster and postherpetic neuralgia. J Pain Res. 2022;15:623\u201332.","journal-title":"J Pain Res"},{"key":"1209_CR42","doi-asserted-by":"crossref","unstructured":"\u2022 Li H, et al. Deficits in ascending and descending pain modulation pathways in patients with postherpetic neuralgia. Neuroimage. 2020;221:117186. Study providing valuable insights into the mechanisms underlying PHN, using imaging and clinical correlations.","DOI":"10.1016\/j.neuroimage.2020.117186"},{"key":"1209_CR43","doi-asserted-by":"crossref","unstructured":"Laing KJ, et al. Immunobiology of varicella-zoster virus infection. J Infect Dis. 2018;218(suppl_2):S68\u201374.","DOI":"10.1093\/infdis\/jiy403"},{"issue":"1","key":"1209_CR44","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12974-018-1360-9","volume":"15","author":"AN Bubak","year":"2018","unstructured":"Bubak AN, et al. Varicella zoster virus differentially alters morphology and suppresses proinflammatory cytokines in primary human spinal cord and hippocampal astrocytes. J Neuroinflammation. 2018;15(1):318.","journal-title":"J Neuroinflammation"},{"key":"1209_CR45","doi-asserted-by":"crossref","unstructured":"Niemeyer CS, et al. VZV infection of primary human adrenal cortical cells produces a proinflammatory environment without cell death. Viruses. 2022;14(4)","DOI":"10.3390\/v14040674"},{"issue":"2","key":"1209_CR46","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1167\/iovs.18-25801","volume":"60","author":"CN Como","year":"2019","unstructured":"Como CN, et al. Varicella zoster virus induces differential cell-type specific responses in human corneal epithelial cells and keratocytes. Invest Ophthalmol Vis Sci. 2019;60(2):704\u201311.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1209_CR47","doi-asserted-by":"crossref","unstructured":"\u2022 Peng Q, et al. Dynamic immune landscape and VZV-specific T cell responses in patients with herpes zoster and postherpetic neuralgia. Front Immunol. 2022;13:887892. The study presents a comprehensive analysis of the immune cell profiles and dynamics in patients with PHN compared to those with herpes zoster.","DOI":"10.3389\/fimmu.2022.887892"},{"key":"1209_CR48","doi-asserted-by":"publisher","first-page":"1183378","DOI":"10.3389\/fimmu.2023.1183378","volume":"14","author":"X Liang","year":"2023","unstructured":"Liang X, Fan Y. Bidirectional two-sample Mendelian randomization analysis reveals a causal effect of interleukin-18 levels on postherpetic neuralgia risk. Front Immunol. 2023;14:1183378.","journal-title":"Front Immunol"},{"issue":"2","key":"1209_CR49","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.abd.2022.03.007","volume":"98","author":"D Lin","year":"2023","unstructured":"Lin D, et al. Serum interleukin-6 levels are increased in post-herpetic neuralgia: a single-center retrospective study. An Bras Dermatol. 2023;98(2):202\u20137.","journal-title":"An Bras Dermatol"},{"key":"1209_CR50","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.3389\/fimmu.2019.03009","volume":"10","author":"AG Vanderwall","year":"2019","unstructured":"Vanderwall AG, Milligan ED. Cytokines in pain: harnessing endogenous anti-inflammatory signaling for improved pain management. Front Immunol. 2019;10:3009.","journal-title":"Front Immunol"},{"issue":"4","key":"1209_CR51","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s12264-019-00346-z","volume":"35","author":"Y Xu","year":"2019","unstructured":"Xu Y, et al. Thymosin alpha-1 inhibits complete Freund\u2019s adjuvant-induced pain and production of microglia-mediated pro-inflammatory cytokines in spinal cord. Neurosci Bull. 2019;35(4):637\u201348.","journal-title":"Neurosci Bull"},{"key":"1209_CR52","doi-asserted-by":"crossref","unstructured":"Chu LW, et al. Loganin prevents chronic constriction injury-provoked neuropathic pain by reducing TNF-alpha\/IL-1beta-mediated NF-kappaB activation and Schwann cell demyelination. Phytomedicine. 2020;67:153166.","DOI":"10.1016\/j.phymed.2019.153166"},{"key":"1209_CR53","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.imlet.2020.11.009","volume":"229","author":"V Fattori","year":"2021","unstructured":"Fattori V, et al. Neuroimmune communication in infection and pain: friends or foes? Immunol Lett. 2021;229:32\u201343.","journal-title":"Immunol Lett"},{"key":"1209_CR54","doi-asserted-by":"crossref","unstructured":"Leo M, et al. Modulation of voltage-gated sodium channels by activation of tumor necrosis factor receptor-1 and receptor-2 in small DRG neurons of rats. Mediators Inflamm. 2015;2015:124942.","DOI":"10.1155\/2015\/124942"},{"key":"1209_CR55","doi-asserted-by":"crossref","unstructured":"Cheng S, et al. Soluble tumor necrosis factor-alpha-induced hyperexcitability contributes to retinal ganglion cell apoptosis by enhancing Nav1.6 in experimental glaucoma. J Neuroinflammation. 2021;18(1)182.","DOI":"10.1186\/s12974-021-02236-6"},{"key":"1209_CR56","doi-asserted-by":"crossref","unstructured":"Zhang Q, Martin-Caraballo M, Hsia SV. Modulation of voltage-gated sodium channel activity in human dorsal root ganglion neurons by herpesvirus quiescent infection. J Virol. 2020;94(3).","DOI":"10.1128\/JVI.01823-19"},{"key":"1209_CR57","doi-asserted-by":"crossref","unstructured":"De Leon-Casasola OA, Mayoral Rojals V. The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence. J Pain Res. 2016;67.","DOI":"10.2147\/JPR.S99231"},{"key":"1209_CR58","doi-asserted-by":"crossref","unstructured":"Wang A, et al. Randomized, placebo-controlled, multicenter clinical study on the efficacy and safety of lidocaine patches in chinese patients with postherpetic neuralgia. Dermatol Ther. 2023;13(7):1477\u201387.","DOI":"10.1007\/s13555-023-00938-8"},{"key":"1209_CR59","doi-asserted-by":"crossref","unstructured":"Castro-Junior CI. Role of calcium permeable channels in pain processing. Sine Loco: IntechOpen; 2018.","DOI":"10.5772\/intechopen.77996"},{"issue":"9","key":"1209_CR60","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1007\/s11010-021-04169-3","volume":"476","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, et al. P2X7 receptor antagonist BBG inhibits endoplasmic reticulum stress and pyroptosis to alleviate postherpetic neuralgia. Mol Cell Biochem. 2021;476(9):3461\u20138.","journal-title":"Mol Cell Biochem"},{"key":"1209_CR61","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.brainresbull.2022.05.003","volume":"185","author":"YY Zhang","year":"2022","unstructured":"Zhang YY, et al. Activation of the N-methyl-D-aspartate receptor contributes to orofacial neuropathic and inflammatory allodynia by facilitating calcium-calmodulin-dependent protein kinase II phosphorylation in mice. Brain Res Bull. 2022;185:174\u201392.","journal-title":"Brain Res Bull"},{"key":"1209_CR62","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.2147\/JPR.S358070","volume":"15","author":"JE Guimar\u00e3es Pereira","year":"2022","unstructured":"Guimar\u00e3es Pereira JE, et al. Efficacy and safety of ketamine in the treatment of neuropathic pain: a systematic review and meta-analysis of randomized controlled trials. J Pain Res. 2022;15:1011\u201337.","journal-title":"J Pain Res"},{"issue":"1","key":"1209_CR63","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1080\/23328940.2022.2075218","volume":"10","author":"LF Iannone","year":"2023","unstructured":"Iannone LF, et al. Neuronal and non-neuronal TRPA1 as therapeutic targets for pain and headache relief. Temperature. 2023;10(1):50\u201366.","journal-title":"Temperature"},{"key":"1209_CR64","doi-asserted-by":"crossref","unstructured":"Tajti J, et al. Exploring novel therapeutic targets in the common pathogenic factors in migraine and neuropathic pain. Int J Mol Sci. 2023;24(4).","DOI":"10.3390\/ijms24044114"},{"issue":"9","key":"1209_CR65","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1016\/j.pain.2011.04.033","volume":"152","author":"Q Hou","year":"2011","unstructured":"Hou Q, et al. Keratinocyte expression of calcitonin gene-related peptide \u03b2: implications for neuropathic and inflammatory pain mechanisms. Pain. 2011;152(9):2036\u201351.","journal-title":"Pain"},{"issue":"8","key":"1209_CR66","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1093\/infdis\/jiy297","volume":"218","author":"AN Bubak","year":"2018","unstructured":"Bubak AN, et al. Varicella zoster virus induces nuclear translocation of the neurokinin-1 receptor, promoting lamellipodia formation and viral spread in spinal astrocytes. J Infect Dis. 2018;218(8):1324\u201335.","journal-title":"J Infect Dis"},{"issue":"5","key":"1209_CR67","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.4049\/jimmunol.1601751","volume":"199","author":"S Suvas","year":"2017","unstructured":"Suvas S. Role of substance P neuropeptide in inflammation, wound healing, and tissue homeostasis. J Immunol. 2017;199(5):1543\u201352.","journal-title":"J Immunol"},{"key":"1209_CR68","doi-asserted-by":"crossref","unstructured":"Yang Y, et al. Aprepitant inhibits JNK and p38\/MAPK to attenuate inflammation and suppresses inflammatory pain. Front Pharmacol. 2021;12:811584.","DOI":"10.3389\/fphar.2021.811584"},{"key":"1209_CR69","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neuroscience.2017.05.030","volume":"356","author":"PR Kramer","year":"2017","unstructured":"Kramer PR, et al. Lateral thalamic control of nociceptive response after whisker pad injection of varicella zoster virus. Neuroscience. 2017;356:207\u201316.","journal-title":"Neuroscience"},{"key":"1209_CR70","doi-asserted-by":"crossref","unstructured":"Hornung R, et al. Reduced activity of GAD67 expressing cells in the reticular thalamus enhance thalamic excitatory activity and varicella zoster virus associated pain. Neurosci Lett. 2020;736:135287.","DOI":"10.1016\/j.neulet.2020.135287"},{"issue":"3","key":"1209_CR71","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ophtha.2019.10.001","volume":"127","author":"CL Kong","year":"2020","unstructured":"Kong CL, et al. Incidence rate of herpes zoster ophthalmicus: a retrospective cohort study from 1994 through 2018. Ophthalmology. 2020;127(3):324\u201330.","journal-title":"Ophthalmology"},{"issue":"2","key":"1209_CR72","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/21645515.2017.1264834","volume":"13","author":"C Alicino","year":"2017","unstructured":"Alicino C, et al. Incidence of herpes zoster and post-herpetic neuralgia in Italy: results from a 3-years population-based study. Hum Vaccin Immunother. 2017;13(2):399\u2013404.","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"1209_CR73","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3344\/kjp.2021.34.4.509","volume":"34","author":"J Kim","year":"2021","unstructured":"Kim J, et al. Pharmacological and non-pharmacological strategies for preventing postherpetic neuralgia: a systematic review and network meta-analysis. Korean J Pain. 2021;34(4):509\u201333.","journal-title":"Korean J Pain"},{"issue":"16","key":"1209_CR74","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1080\/14656566.2017.1392508","volume":"18","author":"J Schutzer-Weissmann","year":"2017","unstructured":"Schutzer-Weissmann J, Farquhar-Smith P. Post-herpetic neuralgia\u2013a review of current management and future directions. Expert Opin Pharmacother. 2017;18(16):1739\u201350.","journal-title":"Expert Opin Pharmacother"},{"issue":"8","key":"1209_CR75","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1111\/ner.13457","volume":"25","author":"CF Wan","year":"2022","unstructured":"Wan CF, Song T. Comparison of two different pulsed radiofrequency modes for prevention of postherpetic neuralgia in elderly patients with acute\/subacute trigeminal herpes zoster. Neuromodulation. 2022;25(8):1364\u201371.","journal-title":"Neuromodulation"},{"key":"1209_CR76","doi-asserted-by":"crossref","unstructured":"Kang DH, et al. Earlier treatment improves the chances of complete relief from postherpetic neuralgia. Korean J Pain. 2017;30(3):214\u20139.","DOI":"10.3344\/kjp.2017.30.3.214"},{"issue":"5","key":"1209_CR77","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1097\/j.pain.0000000000001501","volume":"160","author":"J Kato","year":"2019","unstructured":"Kato J, et al. Mirogabalin for the management of postherpetic neuralgia: a randomized, double-blind, placebo-controlled phase 3 study in Asian patients. Pain. 2019;160(5):1175\u201385.","journal-title":"Pain"},{"issue":"3","key":"1209_CR78","first-page":"32309","volume":"10","author":"C Robinson","year":"2022","unstructured":"Robinson C, et al. A look at commonly utilized serotonin noradrenaline reuptake inhibitors (SNRIs) in chronic pain. Health Psychol Res. 2022;10(3):32309.","journal-title":"Health Psychol Res"},{"issue":"12","key":"1209_CR79","first-page":"1387","volume":"25","author":"J Gudin","year":"2019","unstructured":"Gudin J, et al. Treatment patterns and medication use in patients with postherpetic neuralgia. J Manag Care Spec Pharm. 2019;25(12):1387\u201396.","journal-title":"J Manag Care Spec Pharm"},{"issue":"16","key":"1209_CR80","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMcp1403062","volume":"371","author":"RW Johnson","year":"2014","unstructured":"Johnson RW, Rice AS. Postherpetic neuralgia. N Engl J Med. 2014;371(16):1526\u201333.","journal-title":"N Engl J Med"},{"key":"1209_CR81","doi-asserted-by":"crossref","unstructured":"Feller L, et al. Postherpetic neuralgia and trigeminal neuralgia. Pain Res Treat. 2017;2017.","DOI":"10.1155\/2017\/1681765"},{"key":"1209_CR82","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2147\/JMDH.S106340","volume":"9","author":"T Mallick-Searle","year":"2016","unstructured":"Mallick-Searle T, Snodgrass B, Brant JM. Postherpetic neuralgia: epidemiology, pathophysiology, and pain management pharmacology. J Multidiscip Healthc. 2016;9:447\u201354.","journal-title":"J Multidiscip Healthc"},{"issue":"6","key":"1209_CR83","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s00482-018-0333-3","volume":"32","author":"KU Kern","year":"2018","unstructured":"Kern KU, Schwickert-Nieswandt M. Postherpetic neuralgia of the left trigeminus nerve V1: successful therapy with capsaicin 8% patch. Schmerz. 2018;32(6):464\u20137.","journal-title":"Schmerz"},{"key":"1209_CR84","doi-asserted-by":"crossref","unstructured":"Forstenpointner J, et al. Up-date on clinical management of postherpetic neuralgia and mechanism-based treatment: new options in therapy. J Infect Dis. 2018;218(suppl_2):S120\u20136.","DOI":"10.1093\/infdis\/jiy381"},{"key":"1209_CR85","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.2147\/JPR.S199950","volume":"12","author":"W Pei","year":"2019","unstructured":"Pei W, et al. Is acupuncture an effective postherpetic neuralgia treatment? A systematic review and meta-analysis. J Pain Res. 2019;12:2155\u201365.","journal-title":"J Pain Res"},{"issue":"12","key":"1209_CR86","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1111\/j.1526-4637.2010.01003.x","volume":"11","author":"L Xiao","year":"2010","unstructured":"Xiao L, et al. Subcutaneous injection of botulinum toxin A is beneficial in postherpetic neuralgia. Pain Med. 2010;11(12):1827\u201333.","journal-title":"Pain Med"},{"issue":"1","key":"1209_CR87","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1129-2377-14-92","volume":"14","author":"HS Shehata","year":"2013","unstructured":"Shehata HS, et al. Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia? J Headache Pain. 2013;14(1):92.","journal-title":"J Headache Pain"},{"key":"1209_CR88","doi-asserted-by":"publisher","first-page":"5480728","DOI":"10.1155\/2018\/5480728","volume":"2018","author":"AE Allam","year":"2018","unstructured":"Allam AE, et al. Ultrasound-guided intervention for treatment of trigeminal neuralgia: an updated review of anatomy and techniques. Pain Res Manag. 2018;2018:5480728.","journal-title":"Pain Res Manag"},{"issue":"1","key":"1209_CR89","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.sjpain.2014.10.003","volume":"6","author":"K Takechi","year":"2015","unstructured":"Takechi K, et al. Real-time ultrasound-guided infraorbital nerve block to treat trigeminal neuralgia using a high concentration of tetracaine dissolved in bupivacaine. Scand J Pain. 2015;6(1):51\u20134.","journal-title":"Scand J Pain"},{"issue":"6","key":"1209_CR90","first-page":"E873","volume":"20","author":"A Elawamy","year":"2017","unstructured":"Elawamy A, Abdalla EEM, Shehata GA. Effects of pulsed versus conventional versus combined radiofrequency for the treatment of trigeminal neuralgia: a prospective study. Pain Physician. 2017;20(6):E873\u201381.","journal-title":"Pain Physician"},{"key":"1209_CR91","unstructured":"Li M, et al. The therapeutic efficacy of pulsed radiofrequency alone versus a dexamethasone and pulsed radiofrequency combination in patients with trigeminal postherpetic neuralgia: a double-blind, randomized controlled trial. Pain Physician. 2022;25(4):E543\u20139."},{"key":"1209_CR92","doi-asserted-by":"crossref","unstructured":"Sinofsky A, Sharma T, Wright T. Stellate ganglion block for debilitating photophobia secondary to trigeminal, postherpetic neuralgia. Pain Pract. 2016;16(7):E99\u2013102.","DOI":"10.1111\/papr.12471"},{"key":"1209_CR93","doi-asserted-by":"crossref","unstructured":"Shanthanna H. Utility of stellate ganglion block in atypical facial pain: a case report and consideration of its possible mechanisms. Case Rep Med. 2013;2013:293826.","DOI":"10.1155\/2013\/293826"},{"key":"1209_CR94","doi-asserted-by":"publisher","first-page":"e641","DOI":"10.1016\/j.wneu.2018.03.044","volume":"114","author":"C Velasquez","year":"2018","unstructured":"Velasquez C, et al. Upper cervical spinal cord stimulation as an alternative treatment in trigeminal neuropathy. World Neurosurg. 2018;114:e641\u20136.","journal-title":"World Neurosurg"},{"key":"1209_CR95","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.clineuro.2014.09.023","volume":"127","author":"S Chivukula","year":"2014","unstructured":"Chivukula S, et al. Cervical and cervicomedullary spinal cord stimulation for chronic pain: efficacy and outcomes. Clin Neurol Neurosurg. 2014;127:33\u201341.","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"1209_CR96","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/j.1526-4610.2010.01829.x","volume":"51","author":"ND Tomycz","year":"2011","unstructured":"Tomycz ND, Deibert CP, Moossy JJ. Cervicomedullary junction spinal cord stimulation for head and facial pain. Headache. 2011;51(3):418\u201325.","journal-title":"Headache"},{"key":"1209_CR97","doi-asserted-by":"crossref","unstructured":"Deer TR, et al. The appropriate use of neurostimulation of the spinal cord and peripheral nervous system for the treatment of chronic pain and ischemic diseases: the Neuromodulation Appropriateness Consensus Committee. Neuromodulation. 2014;17(6):515\u201350; discussion 550.","DOI":"10.1111\/ner.12208"},{"key":"1209_CR98","doi-asserted-by":"crossref","unstructured":"Slavin K, et al. Trigeminal and occipital peripheral nerve stimulation for craniofacial pain. a single-institution experience and review of the literature. 2006;2006:21.","DOI":"10.3171\/foc.2006.21.6.8"},{"issue":"6","key":"1209_CR99","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/ner.13288","volume":"24","author":"CF Wan","year":"2021","unstructured":"Wan CF, Song T. Short-term peripheral nerve stimulation relieve pain for elder herpes zoster ophthalmicus patients: a retrospective study. Neuromodulation. 2021;24(6):1121\u20136.","journal-title":"Neuromodulation"},{"key":"1209_CR100","doi-asserted-by":"crossref","unstructured":"Ellis JA, Mejia Munne JC, Winfree CJ. Trigeminal branch stimulation for the treatment of intractable craniofacial pain. J Neurosurg. 2015;123(1):283\u20138.","DOI":"10.3171\/2014.12.JNS14645"},{"key":"1209_CR101","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1007\/s00701-016-2881-6","volume":"158","author":"M Jakobs","year":"2016","unstructured":"Jakobs M, et al. Subcutaneous trigeminal nerve field stimulation for refractory trigeminal pain: a cohort analysis. Acta Neurochir. 2016;158:1767\u201374.","journal-title":"Acta Neurochir"},{"key":"1209_CR102","unstructured":"Hai Jun Shi ZQC. Correlation of serum inflammatory cytokine and immunoglobulin content with post-herpetic neuralgia in patients with acute herpes zoster. J Hainan Med Univ. 2017;23(1):97\u2013100."}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-023-01209-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-023-01209-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-023-01209-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T08:25:37Z","timestamp":1710404737000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-023-01209-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,23]]},"references-count":102,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1209"],"URL":"https:\/\/doi.org\/10.1007\/s11916-023-01209-z","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,23]]},"assertion":[{"value":"29 December 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}